We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

164 hedge funds and large institutions have $1.49B invested in Ironwood Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 61 increasing their positions, 36 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 36

65% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 20

31% more call options, than puts

Call options by funds: $7.83M | Put options by funds: $5.96M

8% more funds holding

Funds holding: 152 → 164 (+12)

7.38% more ownership

Funds ownership: 103.66% → 111.03% (+7.4%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

15% less capital invested

Capital invested by funds: $1.76B → $1.49B (-$273M)

Holders
164
Holders Change
+12
Holders Change %
+7.89%
% of All Funds
3.6%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
33
Increased
61
Reduced
36
Closed
20
Calls
$7.83M
Puts
$5.96M
Net Calls
+$1.87M
Net Calls Change
-$693K

Top Buyers

Rank Fund Capital Flow
1
BCM
Brown Capital Management
Maryland
+$54.4M
2
MP
MFN Partners
Massachusetts
+$14.6M
3
CS
Credit Suisse
Switzerland
+$13.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$11.1M
5
Marshall Wace
Marshall Wace
United Kingdom
+$9.96M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$23.4M
2
Citadel Advisors
Citadel Advisors
Florida
-$15.3M
3
OM
Opaleye Management
Massachusetts
-$5.75M
4
HM
HealthCor Management
New York
-$5.47M
5
FI
Fosun International
China
-$4.75M
Name Holding Trade Value Shares
Change 		Change in
Stake
PNC Financial Services Group
101
PNC Financial Services Group
Pennsylvania
$278K +$9.29K +956 +3%
GAM
102
Gotham Asset Management
New York
$269K +$20.1K +2,066 +7%
TFS
103
TrustCore Financial Services
Tennessee
$258K – – –
TAM
104
Tocqueville Asset Management
New York
$245K – – –
CSS
105
Cubist Systematic Strategies
Connecticut
$238K -$220K -22,649 -45%
BNP Paribas Financial Markets
106
BNP Paribas Financial Markets
France
$237K +$84.3K +8,676 +46%
AB
107
Amalgamated Bank
New York
$234K -$3.94K -405 -1%
XK
108
Xact Kapitalforvaltning
Sweden
$232K – – –
NIT
109
NumerixS Investment Technologies
British Columbia, Canada
$230K +$160K +16,500 +160%
QT
110
Quantamental Technologies
New York
$226K +$256K +26,337 New
AG
111
Aperio Group
California
$222K -$53.2K -5,478 -18%
First Manhattan
112
First Manhattan
New York
$217K -$107K -11,000 -30%
Public Employees Retirement Association of Colorado
113
Public Employees Retirement Association of Colorado
Colorado
$214K – – –
ECM
114
ExodusPoint Capital Management
New York
$214K +$242K +24,897 New
ACM
115
AlphaCrest Capital Management
New York
$209K +$237K +24,400 New
EWM
116
Evercore Wealth Management
New York
$193K – – –
Victory Capital Management
117
Victory Capital Management
Texas
$185K +$210K +21,576 New
Diamond Hill Capital Management
118
Diamond Hill Capital Management
Ohio
$176K +$97.2K +10,000 +95%
GKWIM
119
Gerber Kawasaki Wealth & Investment Management
California
$175K +$199K +20,460 New
CM
120
Caption Management
Oklahoma
$171K +$190K +19,600 +4,900%
II
121
Inspire Investing
Idaho
$169K +$42.1K +4,333 +28%
Jane Street
122
Jane Street
New York
$164K +$186K +19,125 New
SG Americas Securities
123
SG Americas Securities
New York
$147K -$43.6K -4,491 -21%
GC
124
Grimes & Company
Massachusetts
$147K +$166K +17,100 New
VF
125
Virtu Financial
New York
$146K +$165K +16,955 New
3 4
5
6 7

IRWD Hedge Fund Activity: Q3 2019 in Review

164 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q3 2019, worth a combined $1.49B — down 15% from $1.76B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new IRWD positions and 20 closed out — a net gain of 13 holders — while 61 added to existing stakes and 36 trimmed.

The largest buyer was Brown Capital Management, adding an estimated $54.4M. The largest seller was Fidelity Investments, cutting an estimated $23.4M.

  • 164 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q3 2019, up from 152 in Q2 2019.
  • Funds reported $1.49B of Ironwood Pharmaceuticals stock for Q3 2019, down 15% quarter-over-quarter.
  • 33 funds opened new Ironwood Pharmaceuticals positions in Q3 2019 and 20 closed out, a net change of +13 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q3 2019 was Brown Capital Management, an estimated $54.4M added.
  • The largest Ironwood Pharmaceuticals seller in Q3 2019 was Fidelity Investments, an estimated $23.4M sold.

Based on aggregated 13F filings for Q3 2019.